Scarica l'app Stockscreener
39.49
6.76%
2.50
Dopo l'orario di chiusura:
39.64
0.15
+0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics (SLNO) still appears attractive despite slower US launch ramp projections - MSN
Do Ongoing DCCR Lawsuits Reframe Soleno Therapeutics’ (SLNO) Risk Profile More Than Its Drug Potential? - simplywall.st
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - Sahm
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc.SLNO - PR Newswire
Soleno Therapeutics Faces Lawsuit After DCCR Launch Setback and Share Drop - National Today
SLNO INVESTOR ALERT: Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman - ChartMill
Soleno Therapeutics Investors Eligible to Lead Securities Fraud Lawsuit - National Today
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO - GlobeNewswire Inc.
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - accessnewswire.com
Banque Pictet & Cie SA Takes $2.03 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
H.C. Wainwright cuts Soleno Therapeutics stock price target to $100 - Investing.com
Soleno Therapeutics Faces Class Action Lawsuit Over Drug Trial Concerns - National Today
Class Action Lawsuit Filed Against Soleno Therapeutics Over DCCR Disclosures - Intellectia AI
Soleno Therapeutics, Inc. (SLNO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Soleno Therapeutics (SLNO) Faces Securities Class Action - GlobeNewswire
Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline - PR Newswire
Soleno Therapeutics Inc (6XC.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Soleno - GlobeNewswire
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno ... - Bluefield Daily Telegraph
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesSLNO - PR Newswire
Soleno Therapeutics’ (SLNO) Investor Sentiment Subdued Amid Growth Concerns - finance.yahoo.com
SLNO Stock Price, Quote & Chart | SOLENO THERAPEUTICS INC (NASDAQ:SLNO) - ChartMill
Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman - Sahm
REMINDER: Soleno Therapeutics, Inc. Investors With - GlobeNewswire
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud - GuruFocus
(SLNO) Volatility Zones as Tactical Triggers - Stock Traders Daily
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors ... - bdtonline.com
SLNO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky - Morningstar
SLNO PE Ratio & Valuation, Is SLNO Overvalued - Intellectia AI
Soleno Therapeutics (SLNO) Still Appears Attractive Despite Slower U.S. Launch Ramp Projections - Insider Monkey
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application - GlobeNewswire
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
Soleno Therapeutics: Huang sells $200k in shares By Investing.com - Investing.com South Africa
Soleno (NASDAQ: SLNO) SVP sells 6,582 shares to cover RSU tax obligations - Stock Titan
Soleno Therapeutics: Huang sells $200k in shares - Investing.com
Soleno Therapeutics Investors Seek Compensation After Losses - National Today
SLNO Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Soleno Therapeutics (SLNO) Falls Hard on Patient Death - MSN
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 10%Time to Buy? - MarketBeat
Investors Purchase Large Volume of Soleno Therapeutics Call Options (NASDAQ:SLNO) - MarketBeat
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO) - TMX Newsfile
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Cla - GuruFocus
User - The Chronicle-Journal
Soleno Therapeutics Faces Securities Fraud Lawsuit - National Today
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hy - GuruFocus
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman - ChartMill
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities - GlobeNewswire
Deadline Alert: Soleno Therapeutics, Inc. (SLNO) - GlobeNewswire
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):